| Primary |
| Pain |
54.5% |
| Migraine |
9.1% |
| Normal Labour |
9.1% |
| Premature Labour |
9.1% |
| Product Used For Unknown Indication |
9.1% |
| Pruritus |
9.1% |
|
| Somnolence |
16.7% |
| Cardio-respiratory Arrest |
8.3% |
| Drug Dependence |
8.3% |
| Hypoaesthesia |
8.3% |
| Muscle Twitching |
8.3% |
| Pain |
8.3% |
| Pigmentation Disorder |
8.3% |
| Pleural Effusion |
8.3% |
| Skin Discolouration |
8.3% |
| Tachycardia |
8.3% |
| Vomiting |
8.3% |
|
| Secondary |
| Product Used For Unknown Indication |
30.5% |
| Drug Use For Unknown Indication |
10.7% |
| Pain |
10.7% |
| Sickle Cell Anaemia |
8.4% |
| Vomiting |
4.6% |
| General Anaesthesia |
3.1% |
| Maternal Exposure Timing Unspecified |
3.1% |
| Prophylaxis |
3.1% |
| Staphylococcal Sepsis |
3.1% |
| Trigeminal Neuralgia |
3.1% |
| Abdominal Pain |
2.3% |
| Analgesia |
2.3% |
| Febrile Neutropenia |
2.3% |
| Nausea |
2.3% |
| T-cell Type Acute Leukaemia |
2.3% |
| Urinary Tract Infection |
2.3% |
| Analgesic Therapy |
1.5% |
| Chemotherapy |
1.5% |
| Oedema |
1.5% |
| Pseudomonas Infection |
1.5% |
|
| Acute Chest Syndrome |
15.6% |
| Poisoning |
9.4% |
| Urinary Retention |
9.4% |
| Vision Blurred |
9.4% |
| Drug Interaction |
6.3% |
| No Adverse Event |
6.3% |
| Agranulocytosis |
3.1% |
| Clonus |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Exposure During Pregnancy |
3.1% |
| Hypertension |
3.1% |
| Intestinal Obstruction |
3.1% |
| Lower Limb Fracture |
3.1% |
| Neutropenia |
3.1% |
| Pain |
3.1% |
| Rash Generalised |
3.1% |
| Renal Failure Acute |
3.1% |
| Syncope |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Tremor |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.0% |
| Crohn's Disease |
9.4% |
| Pain |
8.3% |
| Drug Use For Unknown Indication |
7.9% |
| Pyrexia |
4.5% |
| Analgesic Therapy |
3.6% |
| Burkitt's Leukaemia |
3.5% |
| Nausea |
3.5% |
| Acute Myeloid Leukaemia |
3.0% |
| Constipation |
2.6% |
| Inflammatory Bowel Disease |
2.6% |
| Pruritus |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Bipolar I Disorder |
2.0% |
| Metastases To Bone |
2.0% |
| Nephroblastoma |
2.0% |
| Breast Cancer |
1.5% |
| Caesarean Section |
1.5% |
| Hypertension |
1.5% |
| Postoperative Care |
1.5% |
|
| Pyrexia |
9.9% |
| Renal Failure Chronic |
8.5% |
| Weight Decreased |
8.5% |
| Multi-organ Failure |
7.0% |
| Vomiting |
7.0% |
| White Blood Cell Count Abnormal |
7.0% |
| Pneumonia |
5.6% |
| Tachycardia |
5.6% |
| Abdominal Abscess |
4.2% |
| Staphylococcal Sepsis |
4.2% |
| Status Migrainosus |
4.2% |
| Thrombocytopenia |
4.2% |
| Unresponsive To Stimuli |
4.2% |
| Acute Monocytic Leukaemia |
2.8% |
| Appendicitis |
2.8% |
| Blood Amylase Increased |
2.8% |
| Colonic Stenosis |
2.8% |
| Drug Ineffective |
2.8% |
| Exostosis |
2.8% |
| Hemiplegia |
2.8% |
|
